文献速递腹部MR

结直肠癌肝转移的晚期钆增强MRI强化与非手术患者总生存期相关

Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.
PubMed 文献 · Eur Radiol · 2019-04-01

这项回顾性研究纳入122例非手术结直肠癌肝转移患者,用靶肿瘤强化(TTE)测量10分钟延迟期钆布醇增强肝脏MRI的晚期强化,分为强TTE与弱TTE两组。Kaplan-Meier分析显示强TTE组2年生存率69.8%高于弱TTE组43.5%(p=0.002),多变量分析中弱TTE与死亡相关(校正HR 0.25,95%CI 0.11-0.59,p=0.002)。

要点

  • 非手术结直肠癌肝转移患者中,强晚期钆增强与更好的总生存期相关。
  • 10分钟延迟期钆布醇增强MRI测量的靶肿瘤强化(TTE)可二分强、弱两组。
  • 强TTE的生存优势在未化疗和已化疗亚组中均可见。

核心结论

  • 结直肠癌肝转移的强晚期钆增强MRI强化与非手术患者的总生存期相关。

研究设计与样本

  • 回顾性研究,经机构研究伦理委员会批准;纳入2006年3月1日至2014年8月31日间接受10分钟延迟期钆布醇增强肝脏MRI的非手术结直肠癌肝转移患者122例,采用靶肿瘤强化(TTE)测量晚期钆增强,将患者二分为强TTE与弱TTE。

诊断标准与关键数值

  • 以靶肿瘤强化(TTE)将患者二分为强TTE与弱TTE;Kaplan-Meier分析2年生存率强TTE组69.8% vs 弱TTE组43.5%(p=0.002);多变量分析(96例数据可用)中弱TTE与死亡相关,校正CEA水平后校正HR 0.25(95%CI 0.11-0.59,p=0.002)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine if late gadolinium MRI enhancement of colorectal liver metastases (CRCLM) is associated with overall survival among nonsurgical patients.

MATERIALS AND METHODS: This retrospective study was approved by the institutional research ethics board. Late gadolinium enhancement was measured using target tumour enhancement (TTE) in all nonsurgical patients with CRCLM who received a 10-min delayed phase gadobutrol-enhanced liver MRI between March 1, 2006, and August 31, 2014. A total of 122 patients met inclusion/exclusion criteria. Patients were dichotomized into strong and weak TTE. Kaplan-Meier and Cox regression statistics were used to determine whether TTE was associated with overall survival. Noncontributory potential confounding variables (age, sex, number and size of metastases, carcinoembryonic (CEA) level, and presence of extrahepatic disease) were excluded from the final Cox regression model using the backward Wald elimination. Subgroup Kaplan-Meier survival analyses were performed on patients who were chemotherapy-naïve and chemotherapy-treated at the time of MRI.

RESULTS: Strong TTE had increased survival compared with those with weak TTE on Kaplan-Meier analysis (2-year survival: 69.8% vs. 43.5%, p = 0.002). Among 96 patients where data was available for multivariable analysis, weak TTE was associated with death (adjusted hazard ratio 0.25, 95% CI 0.11-0.59, p = 0.002), after adjusting for CEA level. Other potential confounders were noncontributory. Subgroup analyses demonstrated that strong TTE had increased survival compared with those with weak TTE in both the chemotherapy-naïve (p = 0.047) and chemotherapy-treated (p = 0.008) groups.

CONCLUSION: Strong late gadolinium MRI enhancement of CRCLM is associated with overall survival among nonsurgical patients.

KEY POINTS: • MRI enhancement of colorectal liver metastases is associated with overall survival in nonsurgical patients. • MRI enhancement of colorectal liver metastases is associated with overall survival in both chemotherapy-naïve and chemotherapy-treated subgroups.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cheung HMC, Kim JK, Hudson J, et al. Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients. Eur Radiol. 2019. PMID: 30937587. doi:10.1007/s00330-019-06177-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。